The GI2 Therapeutic Area Lead in DMPK&M provides scientific and strategic leadership across the Gastrointestinal & Inflammation portfolio, supervising DMPK&M project representatives and Modeling & Simulation scientists who support Takeda’s research pipeline. The role oversees DMPK&M portfolio strategy and execution, including project plans, translation and dose-optimization strategies, and regulatory filing review. It contributes to therapeutic-area discussions, portfolio strategy, and global DMPK&M business operations, and is a member of the Global DMPK&M leadership team, helping shape department strategy, culture, and partnerships across Research and Development. The role provides stage-appropriate scientific guidance to support the selection and development of clinical candidates with optimal drug-development characteristics. It builds external scientific networks, advises on and approves milestone presentations and PRC narratives, and oversees and participates in regulatory activities, including review and approval of submission packages for the GI2 area. As the DMPK&M functional representative in governance and prioritization discussions, the lead aligns DMPK&M strategy with DDU and TAU portfolio goals. The position collaborates with senior leaders, consults with DMPK leadership to align resources and goals, supports in-licensing evaluations, and leads organizational capability and culture development through partnerships across Takeda. The role requires global, cross-functional leadership, sound decision-making, communication, coaching, and the ability to navigate complex internal and external environments.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree